All the news Showing 10 of 204 articles from: Finance, funding & health economicsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources US Veterans Affairs and Australia show potential for rapid elimination of hepatitis C Keith Alcorn / 15 November 2016 If sufficient money is available to pay for direct-acting antivirals (DAAs), the US Veterans Affairs (VA) could cure the majority of veterans under its care of hepatitis C within three years, and ... Bayer warns planned German price curbs may restrict drug access Business Times / 15 November 2016 The Cost Of A Cure: Revisiting Medicare Part D And Hepatitis C Drugs Health Affairs (blog) / 04 November 2016 Huge Spread in Patient Copays for HCV Drugs MedPage Today Gastroenterology / 18 October 2016 Punjab hepatitis control programme on verge of collapse Daily Times / 18 October 2016 NICE says yes to another hepatitis C drug NICE / 26 September 2016 New Study: Negotiated Hepatitis C Prescription Drug Costs in United States Often Lower than in Price-Controlled European Countries and Japan Yahoo News / 20 September 2016 VA estimates 107000 vets have undiagnosed or untreated hepatitis C Stars and Stripes / 07 September 2016 High cost hampers treatment of hepatitis B, C in Vietnam: experts Thanh Nien Daily / 31 August 2016 Why are hepatitis C patients treated differently by NHS England? Pharmaceutical Journal / 15 August 2016 ← Prev1...34567...21Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive